Milestone Pharmaceuticals (MIST) Shares Outstanding (2018 - 2026)

Milestone Pharmaceuticals (MIST) has reported Shares Outstanding (Entity) for 9 consecutive years, with $124.5 million the latest figure, recorded in Q2 2026.

• For the quarter ending Q2 2026, Shares Outstanding (Entity) rose 132.73% year-over-year to $124.5 million; the trailing twelve-month figure through Jun 2026 stood at $124.5 million (up 132.73% YoY), and the FY2025 full-year result was $83.9 million, up 57.22% from the prior year.
• Shares Outstanding (Entity) advanced to $124.5 million in Q2 2026 per MIST's latest filing, from $117.8 million in the prior quarter.
• Across five years, Shares Outstanding (Entity) topped out at $124.5 million in Q2 2026 and bottomed at $34.3 million in Q4 2022.
• Historically, Shares Outstanding (Entity) has averaged $59.1 million across 5 years, with a median of $53.3 million in 2024.
• The sharpest annual moves came in 2022 and 2026: Shares Outstanding (Entity) fell 18.04% in 2022, then surged 132.73% in 2026.
• Over 5 years, Shares Outstanding (Entity) stood at $34.3 million in 2022, then climbed by 25.29% to $43.0 million in 2023, then increased by 24.21% to $53.4 million in 2024, then surged by 57.22% to $83.9 million in 2025, then soared by 48.42% to $124.5 million in 2026.
• According to Business Quant data, Shares Outstanding (Entity) over the past three periods registered $124.5 million, $117.8 million, and $83.9 million for Q2 2026, Q1 2026, and Q4 2025 respectively.